Clinical trial / 2004
Soymilk with isoflavones prevented lumbar spine bone loss in postmenopausal women.
In an 89-woman randomized trial lasting two years, researchers examined the effects of soymilk with isoflavones, transdermal progesterone, or both on bone mineral density. Lumbar spine bone mineral density changes did not differ from zero with isoflavone soymilk (+1.1%) or progesterone alone (-1.1%), but controls lost -4.2% and combined treatment lost -2.8%. Femoral neck bone mineral density did not change significantly in any group.
- Study type
- Randomized controlled trial
- Who was studied
- 89 postmenopausal Caucasian women with osteoporosis or risk factors
- What was measured
- Bone mineral density and content in lumbar spine and hip
THE PAPER
Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial.
Lydeking-Olsen E, Beck-Jensen JE, Setchell KD, Holm-Jensen T. Eur J Nutr, 2004.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.